Intermountain End-Stage Renal Dise… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1978

Legal Domicile

Principal Officer

Darlene Rodgers

Phone

7202351580

Tax Period

2020-01-01 to 2020-12-31

Intermountain End-Stage Renal Disease Network Inc, founded in 1978, is a small nonprofit that reported $402K in total revenue in fiscal year 2020. Revenue grew 11% year-over-year, indicating healthy expansion.

Mission

The mission/vision of Intermountain Quality Innovations (ImQI) is to advance the improvement of healthcare quality provided to people with acute and chronic conditions, including ESRD, through clinical & logistical support, provider/patient/family education, research, data collection, and analysis.

Program Service Accomplishments

Program 1

Expenses: $344,597 Revenue: $401,742

Intermountain End-Stage Renal Disease Network, Inc. is doing business as Intermountain Quality Innovations (ImQI). During 2020, ImQI collaborated with Comagine/HealthInsight-Nevada on phase two of a Centers for Medicare and Medicaid Services-funded initiative to reduce potentially avoidable hospitalizations in the Nursing Home setting, with the American Society of Nephrology on preventing infection in dialysis units and disaster preparation for the nephrology community.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2020)

Revenue Breakdown

Contributions & Grants $0

Program Service Revenue $401,742

Investment Income $576

Other Revenue $0

TOTAL REVENUE $402,318

Expense Breakdown

Grants Paid $0

Salaries & Benefits $366,932

Fundraising Expenses $0

Program Expenses $344,597

Other Expenses $53,868

TOTAL EXPENSES $420,800

Year-over-Year Comparison

	2020	2019	Change
Revenue	$402,318	$363,001	+0.1%
Expenses	$420,800	$628,550	-0.3%
Net Income	$-18,482	$-265,549	-0.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$146,708

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Michael Fisher	Treasurer/Secretary	1.00	Officer Director	$0	$0	$0
Cynthia Kristensen MD	President	1.00	Officer Director	$0	$0	$0
Tamara Hoxworth PhD	Director	1.00	Director	$0	$0	$0
Larry Coffee DDS	Director	1.00	Director	$0	$0	$0
Darlene Rodgers	CEO	40.00	Officer	$140,255	$6,453	$146,708

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2020	$402,318	$420,800	$158,664	$-18,482
2019	$363,001	$628,550	$125,090	$-265,549
2018	$312,557	$677,089	$405,069	$-364,532

Intermountain End-Stage Renal Disease Network Inc